NCT07035964

Effects of Effera Human Lactoferrin at One Dose Compared to Placebo on Gut Permeability

Randomized, Double-Blind, Placebo-Controlled, Parallel Study on the Effects of Effera Human Lactoferrin on Gastrointestinal Permeability

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 46 (estimated)
• Sponsor: Helaina Inc. · Industry
• Sex: All
• Age: 18 Years – 40 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the impact of 28-day supplementation with effera human lactoferrin, compared to a placebo control product on indicators of gut barrier health in males and females

Detailed description

Samples will be retained for possible analyses such lactoferrin absorption and immune biomarkers

Conditions

• Gut Permeability
• Gut Health

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	human lactoferrin	effera human lactoferrin
DIETARY_SUPPLEMENT	Placebo	Placebo Control

Timeline

• Start date: 2025-06-04
• Primary completion: 2025-08-30
• Completion: 2025-08-30
• First posted: 2025-06-25
• Last updated: 2025-06-25

Locations

1 site across 1 country: United States